SNMMI 2016 Articles

Articles

SNMMI 2016: PET/CT Imaging of Prostate Cancer Proves Accurate Biopsy Guide

Study shows imaging of prostate-specific membrane antigen leads to highly accurate tumor detection and delineation

San Diego, Calif. (June 15, 2016) – Prostate cancer is the leading cancer among men, second only to skin cancer. With surgical removal at the frontline of defense, oncologists are considering prostate-specific molecular imaging at the point of initial biopsy and pre-operative planning to root out the full extent of disease, researchers revealed at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Published July 11, 2016
Using Fluciclovine in the Recurrent Prostate Cancer Patient- David Schuster
Presentation from the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. (Length of lecture 57 minutes)

In this lecture, David Schuster describes the mechanisms of uptake of the PET radiotracer fluciclovine and identifies normal biodistribution of fluciclovine. In addition, Dr. Schuster discusses the FDA approval and clinical indication of fluciclovine and the clinical interpretive criteria of fluciclovine PET

Biography:
Dr. David Schuster is Director of the Division of Nuclear Medicine and Molecular Imaging and is a Georgia Research Alliance Distinguished Scientist. He serves in an NIH study section and reviews for medical journals. Dr. Schuster is widely published and has lectured nationally and internationally. Dr. Schuster is the recipient of the Society of Nuclear Medicine Tetalman Award and is also known for his co-authorship of the book “A Clinician’s Guide to Nuclear Medicine”.

Additional reading on topic:

Cristina Nanni on Flucicovine F18 (FACBC) in Prostate Cancer - State of the Art Presentation

EVERYDAY UROLOGY: Axumin™ [Fluciclovine F18]: An Accurate Imaging Approach for Patients with Biochemically Recurrent Prostate Cancer-Full text article

Published August 21, 2017

SNMMI 2016 Articles

Articles

SNMMI 2016: PET/CT Imaging of Prostate Cancer Proves Accurate Biopsy Guide

Using Fluciclovine in the Recurrent Prostate Cancer Patient- David Schuster

Login